NDC 61755-012
Pasatru 300 mg per 5 mL injection, solution, concentrate
On the label: Regeneron Pharmaceuticals, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | Rensselaer, NY, United States | Makes the active ingredient and tests it | Problems found, fixed voluntarilyMar 22, 2024 · 10 inspections |
| Simtra US LLC | Bloomington, IN, United States | Makes it and tests it | Problems found, fixed voluntarilySep 24, 2024 · 12 inspections |
| Nelson Laboratories, LLC | Salt Lake City, UT, United States | Tests it | Problems found, fixed voluntarilyJun 2, 2023 · 6 inspections |
| Sharp Packaging Services, LLC | Allentown, PA, United States | Packages it | No problems foundNov 21, 2025 · 7 inspections |
Product details
- Generic drug
- Garetosmab: every company that makes it
- Form
- injection, solution, concentrate, intravenous
- Strength
- 300 mg per 5 mL
- Approval
- BLA BLA761508
- On the market since
- Aug 19, 2026
- Package NDCs
61755-012-0061755-012-01- Official label
- DailyMed (National Library of Medicine), updated Aug 14, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?